Abstract:Patients with chronic inflammation are often associated with the emergence of depression symptoms, while diagnosed depressed patients show increased levels of circulating cytokines. Further studies revealed the activation of the brain immune cell microglia in depressed patients with a greater magnitude in individuals that committed suicide, indicating a crucial role for neuroinflammation in depression brain pathogenesis. Rapid advances in the understanding of microglial and astrocytic neurobiology were obtained in the past 15-20 years. Indeed, recent data reveal that microglia play an important role in managing neuronal cell death, neurogenesis, and synaptic interactions, besides their involvement in immune-response generating cytokines. The communication between microglia and neurons is essential to synchronize these diverse functions with brain activity. Evidence is accumulating that secreted extracellular vesicles (EVs), comprising ectosomes and exosomes with a size ranging from 0.1-1 μm, are key players in intercellular signaling. These EVs may carry specific proteins, mRNAs and microRNAs (miRNAs). Transfer of exosomes to neurons was shown to be mediated by oligodendrocytes, microglia and astrocytes that may either be supportive to neurons, or instead disseminate the disease. Interestingly, several recent reports have identified changes in miRNAs in depressed patients, which target not only crucial pathways associated with synaptic plasticity, learning and memory but also the production of neurotrophic factors and immune cell modulation. In this article, we discuss the role of neuroinflammation in the emergence of depression, namely dynamic alterations in the status of microglia response to stimulation, and how their activation phenotypes may have an etiological role in neurodegeneneration, in particular in depressive-like behavior. We will overview the involvement of miRNAs, exosomes, ectosomes and microglia in regulating critical pathways associated with depression and how they may contribute to other brain disorders including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and Parkinson's disease (PD), which share several neuroinflammatory-associated processes. Specific reference will be made to EVs as potential biomarkers and disease monitoring approaches, focusing on their potentialities as drug delivery vehicles, and on putative therapeutic strategies using autologous exosome-based delivery systems to treat neurodegenerative and psychiatric disorders.

Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression: A literature review

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

Microglial Inflammatory Mechanisms in Stroke: The Jury Is Still Out

Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes

Role and characteristics of hippocampal region microglial activation in poststroke depression

Effect of Inflammation on the Process of Stroke Rehabilitation and Poststroke Depression

Microglial phagocytosis and regulatory mechanisms after stroke

Specific depletion of resident microglia in the early stage of stroke reduces cerebral ischemic damage

Regulation of microglia polarization after cerebral ischemia

Microglia Sing the Prelude of Neuroinflammation-Associated Depression

The Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery

Common Cellular and Molecular Mechanisms and Interactions Between Microglial Activation and Aberrant Neuroplasticity in Depression

The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review

Possible Implications of Obesity-Primed Microglia that Could Contribute to Stroke-Associated Damage

Inflammation within the neurovascular unit: Focus on microglia for stroke injury and recovery

Role of microglia in stroke

Receptors, Channel Proteins, and Enzymes Involved in Microglia-mediated Neuroinflammation and Treatments by Targeting Microglia in Ischemic Stroke

Microglial Phenotypic Transition: Signaling Pathways and Influencing Modulators Involved in Regulation in Central Nervous System Diseases

Activation of Inflammasomes and Relevant Modulators for the Treatment of Microglia-mediated Neuroinflammation in Ischemic Stroke

Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation

Microglia-mediated inflammatory destruction of neuro-cardiovascular dysfunction after stroke